Arca
Skip to content

ACVR1: Activin receptor type-1

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Bone morphogenetic protein (BMP) type I receptor that is involved in a wide variety of biological processes, including bone, heart, cartilage, nervous, and reproductive system development and regulation.

  • Drugs that act on it: 4
  • With a US drug page: 2
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
MomelotinibApprovedActivin receptor type-1 inhibitorInhibitor—
PacritinibApprovedActivin receptor type-1 inhibitorInhibitor—
Dibotermin alfa—Activin receptor type-1 agonistAgonist—
Eptotermin alfa—Activin receptor type-1 agonistAgonist—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Neoplasm
0.51
Neurodegenerative disease
0.48
Hereditary disease
0.47
Bone disorder
0.46
Tibia fracture
0.46
Myeloproliferative disorder
0.41
Acquired polycythemia vera
0.40
Splenomegaly
0.37

Drugs and mechanisms are from ChEMBL CHEMBL5903 (CC BY-SA 3.0). Gene name, function (UniProt Q04771, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.